 |
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Name: | Regorafenib | Cas: | 835621-07-3 |
|---|---|---|---|
| Mf: | C21H16Cl2F4N4O3 | Purity: | 99% |
| Appearance: | White Powder | Package: | 1kg/bag Or 25kgs/drum |
| High Light: | Anti Cancer Regorafenib,835621-07-3 Regorafenib,Regorafenib Monohydrate |
||
Regorafenib Hydrochloride Anti-Cancer CAS 835621-07-3 API Regorafenib Raw Material
| Product Name | Regorafenib |
| Appearance | White Powder |
| CAS No. | 835621-07-3 |
| MF | C21H16Cl2F4N4O3 |
Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.
| Adenosine | AR | 58-61-7 | ≥99% |
| Uridine | UR | 58-96-8 | ≥99% |
| Cytidine | CR | 65-46-3 | ≥99% |
| Xanthosine 5-monophosphate disodium salt | XMP- Na2 | 25899-70-1 | ≥98% |
| Inosine-5'-monophosphate disodium salt octahydrate | IMP- Na2 | 20813-76-7 | ≥98% |
| Adenosine 5′-monophosphate disodium salt | AMP- Na2 | 4578-31-8 | ≥98% |
| Adenosine 5'-Monophosphatesodiumsalt | AMP- Na | .13474-03-8 | ≥98% |
| 5-Adenylic acid | AMP | 61-19-8 | ≥98% |
| Adenosine 3',5'-cyclic monophosphate | Cyclic AMP,CAMP | 60-92-4 | ≥97% |
| Uridine 5-monophosphate, disodium salt | UMP- Na2 | 3387-36-8 | ≥98% |
| Uridine 5'-monophosphate | UMP | 58-97-9 | ≥98% |
| Cytidine 5''-monophosphate disodium salt | CMP- Na2 | .6757-06-8 | ≥98% |
| Cytidine 5′-monophosphate | CMP | 63-37-6 | ≥98% |
| Citicoline sodium | CDPC-Na | 33818-15-4 | ≥98% |
| uridine 5'-diphosphate disodium salt | UDP-Na2 | 27821-45-0 | ≥95% |
| IDP-K2 | ≥90% | ||
| Inosine-5'-diphosphoric acid disodium salt | IDP-Na2 | 54735-61-4 | ≥90% |
| Cytidine 5'-Diphosphate Trisodium Salt Hydrate | CDP-Na3 | 34393-59-4 | ≥90% |
| Cytidine-5'-diphosphate disodium salt | CDP-Na2 | 54394-90-0 | ≥90% |
| Adenosine 5'-diphosphate dipotassiuM salt | ADP-K2 | 114702-55-5 | ≥95% |
| Adenosine-5'-diphosphate, MonopotassiuM salt | ADP-K | 72696-48-1 | ≥95% |
| Adenosine-5-diphosphate disodium salt | ADP-Na2 | 16178-48-6 | ≥95% |
| Adenosine 5''-diphosphate sodium salt | ADP-Na | 20398-34-9 | ≥95% |
| Adenosine 5''-diphosphate | ADP | 58-64-0 | ≥95% |
| Uridine 5'-triphosphate disodium salt | UTP-Na3 | 19817-92-6 | ≥90% |
| Uridine-5'-triphosphoric acid trisodium salt | UTP-Na2 | 285978-18-9 | ≥90% |
| CTP-Na3 | ≥95% | ||
| Cytidine 5′-triphosphate disodium salt | CTP-Na2 | 36051-68-0 | ≥95% |
| Adenosine 5'-triphosphate disodium salt | ATP-Na2 | 987-65-5 | ≥95% |
| Adenosin-5'-triphosphat | ATP | 56-65-5 |
Contact Person: July
Tel: 25838890
